[
  {
    "text": " Andr&#x000E9;, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., et al. (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350, 2343&#x02013;2351.", 
    "pmid": "15175436"
  }, 
  {
    "text": " Bornstein, J. C., Costa, M., and Grider, J. R. (2004). Enteric motor and interneuronal circuits controlling motility. Neurogastroenterol. Motil. 16, 34&#x02013;38.", 
    "pmid": "15066002"
  }, 
  {
    "text": " Bornstein, J. C., Marks, K. A., Foong, J. P., Gwynne, R. M., and Wang, Z. H. (2010). Nitric oxide enhances inhibitory synaptic transmission and neuronal excitability in Guinea-pig submucous plexus. Front. Neurosci. 4:30. doi: 10.3389/fnins.2010.00030", 
    "pmid": "20589236"
  }, 
  {
    "text": " Burzynski, G., Shepherd, I. T., and Enomoto, H. (2009). Genetic model system studies of the development of the enteric nervous system, gut motility and Hirschsprung&#x00027;s disease. Neurogastroenterol. Motil. 21, 113&#x02013;127.", 
    "pmid": "19215589"
  }, 
  {
    "text": " Cavaletti, G., Tredici, G., Petruccioli, M. G., Dond&#x000E8;, E., Tredici, P., Marmiroli, P., et al. (2001). Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer 37, 2457&#x02013;2463.", 
    "pmid": "11720843"
  }, 
  {
    "text": " de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., et al. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol. 18, 2938&#x02013;2947.", 
    "pmid": "10944126"
  }, 
  {
    "text": " Dickson, E. J., Spencer, N. J., Hennig, G. W., Bayguinov, P. O., Ren, J., Heredia, D. J., et al. (2007). An enteric occult reflex underlies accommodation and slow transit in the distal large bowel. Gastroenterology 132, 1912&#x02013;1924.", 
    "pmid": "17484884"
  }, 
  {
    "text": " Di Fiore, F., and Van Cutsem, E. (2009). Acute and long-term gastrointestinal consequences of chemotherapy. Best Pract. Res. Clin. Gastroenterol. 23, 113&#x02013;124.", 
    "pmid": "19258191"
  }, 
  {
    "text": " Fuertes, M. A., Castilla, J., Alonso, C., and P&#x000E9;rez, J. M. (2003). Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr. Med. Chem. 10, 257&#x02013;266.", 
    "pmid": "12570712"
  }, 
  {
    "text": " Furness, J. B. (2006). The Enteric Nervous System. Oxford: Blackwell Publishing."
  }, 
  {
    "text": " Furness, J. B., Nguyen, T. V., Nurgali, K., and Shimizu, Y. (2008). &#x0201C;The enteric nervous system and its extrinsic connections,&#x0201D; in The Textbook of Gastroenterology, 5th Edn., ed T. Yamada (Philadelphia, PA: Lippincott, Williams and Wilkins), 15&#x02013;39."
  }, 
  {
    "text": " Gill, J. S., and Windebank, A. J. (1998). Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J. Clin. Investig. 101, 2842&#x02013;2850.", 
    "pmid": "9637718"
  }, 
  {
    "text": " Gonzalez-Zulueta, M., Ensz, L. M., Mukhina, G., Lebovitz, R. M., Zwacka, R. M., Engelhardt, J. F., et al. (1998). Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18, 2040&#x02013;2055.", 
    "pmid": "9482791"
  }, 
  {
    "text": " Gwynne, R. M., Thomas, E. A., Goh, S. M., Sj&#x000F6;vall, H., and Bornstein, J. C. (2004). Segmentation induced by intraluminal fatty acid in isolated guinea-pig duodenum and jejunum. J. Physiol. 556, 557&#x02013;569.", 
    "pmid": "14754993"
  }, 
  {
    "text": " Hector, S., Bolanowska-Higdon, W., Zdanowicz, J., Hitt, S., and Pendyala, L. (2001). In vitro studies on the mechanisms of oxaliplatin resistance. Cancer Chemother. Pharmacol. 48, 398&#x02013;406.", 
    "pmid": "11761458"
  }, 
  {
    "text": " Holmes, J., Stanko, J., Varchenko, M., Ding, H., Madden, V. J., Bagnell, C. R., et al. (1998). Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a wistar rat model. Toxicol. Sci. 46, 342&#x02013;351.", 
    "pmid": "10048138"
  }, 
  {
    "text": " Kweekel, D. M., Gelderblom, H., and Guchelaar, H. J. (2005). Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy. Cancer Treat. Rev. 31, 90&#x02013;105.", 
    "pmid": "15847979"
  }, 
  {
    "text": " Leonard, G. D., Wright, M. A., Quinn, M. G., Fioravanti, S., Harold, N., Schuler, B., et al. (2005). Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer 5:116. doi: 10.1186/1471-2407-5-116", 
    "pmid": "16168057"
  }, 
  {
    "text": " Lewis, T. S., Shapiro, P. S., and Ahn, N. G. (1998). Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49&#x02013;139.", 
    "pmid": "9561267"
  }, 
  {
    "text": " Linden, D. R., Sharkey, K. A., and Mawe, G. M. (2003). Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon. J. Physiol. 547, 589&#x02013;601.", 
    "pmid": "12562910"
  }, 
  {
    "text": " Lomax, A. E., O&#x00027;Hara, J. R., Hyland, N. P., Mawe, G. M., and Sharkey, K. A. (2007). Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G482&#x02013;G491.", 
    "pmid": "17008554"
  }, 
  {
    "text": " Louvet, C., Andr&#x000E9;, T., Tigaud, J. M., Gamelin, E., Douillard, J. Y., Brunet, R., et al. (2002). Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J. Clin. Oncol. 20, 4543&#x02013;4548.", 
    "pmid": "12454110"
  }, 
  {
    "text": " Machover, D., Diaz-Rubio, E., de Gramont, A., Schilf, A., Gastiaburu, J. J., Brienza, S., et al. (1996). Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann. Oncol. 7, 95&#x02013;98.", 
    "pmid": "9081400"
  }, 
  {
    "text": " McDonald, E. S., Randon, K. R., Knight, A., and Windebank, A. J. (2005). Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol. Dis. 18, 305&#x02013;313.", 
    "pmid": "15686959"
  }, 
  {
    "text": " Mihara, Y., Egashira, N., Sada, H., Kawashiri, T., Ushio, S., Yano, T., et al. (2011). Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats. Mol. Pain 7, 8&#x02013;15.", 
    "pmid": "21247499"
  }, 
  {
    "text": " Nurgali, K., Nguyen, T. V., Matsuyama, H., Thacker, M., Robbins, H. L., and Furness, J. B. (2007). Phenotypic changes of morphologically identified guinea-pig myenteric neurons following intestinal inflammation. J. Physiol. 583, 593&#x02013;609.", 
    "pmid": "17615102"
  }, 
  {
    "text": " Nurgali, K., Qu, Z., Hunne, B., Thacker, M., Pontell, L., and Furness, J. B. (2011). Morphological and functional changes in guinea-pig neurons projecting to the ileal mucosa at early stages after inflammatory damage. J. Physiol. 589, 325&#x02013;339.", 
    "pmid": "21098001"
  }, 
  {
    "text": " Petrioli, R., Pascucci, A., Francini, E., Marsili, S., Sciandivasci, A., Tassi, R., et al. (2008). Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin. Cancer Chemother. Pharmacol. 61, 105&#x02013;111.", 
    "pmid": "17429632"
  }, 
  {
    "text": " Raymond, E., Faivre, S., Chaney, S., Woynarowski, J., and Cvitkovic, E. (2002). Cellular and molecular pharmacology of oxaliplatin. Mol. Cancer Ther. 1, 227&#x02013;235.", 
    "pmid": "12467217"
  }, 
  {
    "text": " Rivera, L. R., Pontell, L., Cho, H. J., Castelucci, P., Thacker, M., Poole, D. P., et al. (2012). Knock out of neuronal nitric oxide synthase exacerbates intestinal ischemia/reperfusion injury in mice. Cell Tissue Res. 349, 565&#x02013;576.", 
    "pmid": "22688956"
  }, 
  {
    "text": " Rivera, L. R., Poole, D. P., Thacker, M., and Furness, J. B. (2011). The involvement of nitric oxide synthase neurons in enteric neuropathies. Neurogastroenterol. Motil. 23, 980&#x02013;988.", 
    "pmid": "21895878"
  }, 
  {
    "text": " Roberts, R. R., Bornstein, J. C., Bergner, A. J., and Young, H. M. (2008). Disturbances of colonic motility in mouse models of Hirschsprung&#x00027;s disease. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G996&#x02013;G1008.", 
    "pmid": "18276829"
  }, 
  {
    "text": " Roberts, R. R., Murphy, J. F., Young, H. M., and Bornstein, J. C. (2007). Development of colonic motility in the neonatal mouse-studies using spatiotemporal maps. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G930&#x02013;G938.", 
    "pmid": "17158255"
  }, 
  {
    "text": " Scuteri, A., Galimberti, A., Maggioni, D., Ravasi, M., Pasini, S., Nicolini, G., et al. (2009). Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology 30, 312&#x02013;319.", 
    "pmid": "19428505"
  }, 
  {
    "text": " Ta, L. E., Espeset, L., Podratz, J., and Windebank, A. J. (2006). Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum&#x02013;DNA binding. Neurotoxicology 27, 992&#x02013;1002.", 
    "pmid": "16797073"
  }, 
  {
    "text": " Takeda, K., and Ichijo, H. (2002). Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system. Genes Cells 7, 1099&#x02013;1111.", 
    "pmid": "12390245"
  }, 
  {
    "text": " Vera, G., Castillo, M., Cabezos, P. A., Chiarlone, A., Mart&#x000ED;n, M. I., Gori, A., et al. (2011). Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterol. Motil. 23, 370&#x02013;378.", 
    "pmid": "21299719"
  }, 
  {
    "text": " Visovsky, C. (2003). Chemotherapy-induced peripheral neuropathy. Cancer Investig. 21, 439&#x02013;451.", 
    "pmid": "12901290"
  }, 
  {
    "text": " Wang, D., and Lippard, S. J. (2005). Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4, 307&#x02013;320.", 
    "pmid": "15789122"
  }, 
  {
    "text": " Woynarowski, J. M., Chapman, W. G., Napier, C., Herzig, M. C., and Juniewicz, P. (1998). Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Mol. Pharmacol. 54, 770&#x02013;777.", 
    "pmid": "9804612"
  }, 
  {
    "text": " Yagihashi, N., Kasajima, H., Sugai, S., Matsumoto, K., Ebina, Y., Morita, T., et al. (2000). Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch. 436, 109&#x02013;114.", 
    "pmid": "10755599"
  }, 
  {
    "text": " Yuan, S. Y., Bornstein, J. C., and Furness, J. B. (1995). Pharm-acological evidence that nitric oxide may be a retrograde messenger in the enteric nervous system. Br. J. Pharmacol. 114, 428&#x02013;432.", 
    "pmid": "7533617"
  }
]